1 Min Read
Aug 28 (Reuters) - Sinopharm Group Co Ltd
* HY profit attributable to owners of parent RMB2.76 billion versus RMB2.53 billion
* HY revenue RMB 137.77 billion versus RMB 126.80 billion Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.